Medical Xpress – Quotes Paul Barr, assistant professor of The Dartmouth Institute for Health Policy and Clinical Practice, about the disconnect between the priorities of patients and clinicians when it comes to the information needed to make decisions about treatment options for depression.
Articles by: Geisel Communications
Dartmouth Addiction Expert To Attend State Of The Union Address
NHPR – Seddon Savage, adjunct associate professor of anesthesiology and director of the Dartmouth Center on Addiction Recovery and Education, who is also one of New Hampshire’s top experts on the opioid crisis, will be attending President Obama’s State of the Union address. Savage chairs a task force on prescription drug abuse for the New Hampshire Medical Society and serves on the governor’s commission on Alcohol and Drug Abuse. She will be a guest of U.S. Senator Kelly Ayotte at Tuesday night’s speech.
Congress Approves Bill to Require Childproof Packaging for E-Cigs
USA Today – Quotes Susanne Tanski, associate professor of pediatrics, about Congress’ recent passing of legislation to require child-resistant packaging for the liquids that give e-cigarette both their kick and their flavor. “This is a really important piece of common-sense legislation,” says Tanski. “Nicotine is quite a powerful drug that has complex effects on the body, including the brain and the whole nervous system.”
Virtual Reality Could Provide Healthy Escape for Homesick Astronauts
VICE – Continued coverage of comments by Jay Buckey, professor of medicine and adjunct professor of engineering, who is leading a team deep into the Arctic to test whether exposure to nature through virtual reality can help improve mood and stress levels. “Being in an environment like that where you’re in a small, confined space with a very small group of people means that challenges are just going to inevitably arise,” says Buckey.
Illumina Creating Company to Develop Early-Stage Cancer Detection Test
The New York Times – Quotes H. Gilbert Welch, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, about whether some forms of cancer screening, like PSA testing for prostate cancer or mammography, are even advisable.
Follow-Up of Screening Results Vary Between Breast, Cervical, and Colorectal Cancers
Oncology Nurse Advisor – Article quotes Anna Tosteson, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, and lead author of a recent study that found follow-up appointments for patients whose screening examinations showed abnormal findings occurred faster for findings of breast cancer than for colorectal and cervical cancers.
Why Doctors Shouldn’t Be Punished for Giving Prostate Tests
The New York Times – An opinion piece co-authored by H. Gilbert Welch, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, about how he hopes that Medicare chooses not to pursue a strategy of penalizing doctors for ordering prostate-specific antigen, or PSA, tests.
Plant Virus Shows Potential as a Cancer Treatment
Mental Floss – Continued coverage of comments by Steven Fiering, professor of microbiology and immunology and genetics, who led research with colleagues from Case Western University that found that exposure to tiny pieces of cowpea mosaic virus shell can prompt the immune system to begin attacking tumors.
Biased DTC Ads Raise Fresh Concern Among Physicians
OncLive – Cites research conducted by Lisa Schwartz and Steven Woloshin, both professors of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, to develop drug fact boxes for advertisements and prescription information that would provide more comprehensive data for use in interpreting the value of various medications.
The Problem With Sleeping Pills
Consumer Reports – Quotes Lisa Schwartz, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, about how the risks of drugs to treat sleep problems may outweigh the benefits.